Jakob Robert Izbicki
Overview
Explore the profile of Jakob Robert Izbicki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
302
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hoeppner J, Brunner T, Schmoor C, Bronsert P, Kulemann B, Claus R, et al.
N Engl J Med
. 2025 Jan;
392(4):323-335.
PMID: 39842010
Background: The best multimodal approach for resectable locally advanced esophageal adenocarcinoma is unclear. An important question is whether perioperative chemotherapy is preferable to preoperative chemoradiotherapy. Methods: In this phase 3,...
2.
Gotze J, Meissner K, Pereira-Veiga T, Belloum Y, Schneegans S, Kropidlowski J, et al.
J Exp Clin Cancer Res
. 2025 Jan;
44(1):14.
PMID: 39815324
Background: The lack of predictive biomarkers contributes notably to the poor outcomes of patients with pancreatic ductal adenocarcinoma (PDAC). Cancer-associated fibroblasts (CAFs) are the key components of the prominent PDAC...
3.
Stuben B, Plitzko G, Stern L, Schmeding R, Karstens K, Reeh M, et al.
J Clin Med
. 2024 Feb;
13(4).
PMID: 38398449
Background: Esophagectomy carries a high risk of morbidity and mortality compared to other major surgeries. With the aim of creating an easy-to-use clinical preoperative risk assessment tool and to validate...
4.
Tachezy M, Gebauer F, Yekebas E, Izbicki J
Cancers (Basel)
. 2023 Sep;
15(17).
PMID: 37686537
Background: A significant number of clinical trials must be prematurely discontinued due to recruitment failure, and only a small fraction publish results and a failure analysis. Based on our experience...
5.
RAI3 expression is not associated with clinical outcomes of patients with non-small cell lung cancer
Melling N, Reeh M, Ghadban T, Tachezy M, Hajek A, Izbicki J, et al.
J Cancer Res Clin Oncol
. 2023 Feb;
149(9):6549-6555.
PMID: 36781501
Purpose: Retinoic acid inducible protein 3 (RAI3) has been suggested as prognostic biomarker in several cancer types. The present study aimed to examine the role of RAI3 expression in non-small...
6.
Stern L, Boehme L, Goetz M, Nitschke C, Giannou A, Zhang T, et al.
Int J Oncol
. 2022 Nov;
62(1).
PMID: 36382671
Bitter taste receptors (T2Rs) are G protein‑coupled receptors originally detected in the gustatory system. More recently, T2Rs have been shown to be expressed in extra‑oral cells eliciting non‑gustatory functions. Emerging...
7.
Molwitz I, Kemper M, Krause L, Adam G, Izbicki J, Burdelski C, et al.
Ann Transl Med
. 2022 Oct;
10(18):955.
PMID: 36267707
Background: The role of the computed tomography (CT)-derived skeletal muscle index (SMI) as a parameter of muscle quantity on the outcome after major liver resection remains contradictory and that of...
8.
Stuben B, Stuhlfelder J, Kemper M, Tachezy M, Ghadban T, Izbicki J, et al.
Cancers (Basel)
. 2022 Feb;
14(4).
PMID: 35205833
Esophageal cancer is the eighth most common cancer worldwide, with poor prognosis and high mortality. The combination of surgery and systemic therapy provide the best chances for long-term survival. The...
9.
Bellon E, Grupp K, Ghadban T, Tachezy M, Bachmann K, Izbicki J, et al.
J Cancer Res Clin Oncol
. 2021 Jun;
147(10):2879-2884.
PMID: 34148155
Introduction: Lysophosphatidylcholine acyltransferase 1 (LPCAT1) has repeatedly been suggested to be associated with tumorigenesis. To evaluate the role of LPCAT1 in esophageal cancer, LPCAT1 immunostaining was analyzed on a tissue...
10.
Kersting S, Gotz M, Uzunoglu F, Uhl W, Izbicki J, Blessin N, et al.
Chirurg
. 2021 May;
93(1):72-81.
PMID: 33938959
Background: Malignant solid pseudopapillary neoplasms (SPN) are rare tumor entities of the pancreas. The prognosis for SPN is generally excellent, although some tumors have malignant potential and tend to metastasize...